ABBVIE, INC. for ABBVIE INC.
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Taxation/Internal Revenue Code TAX
Implementation of H.R. 1, Bill to provide for reconciliation pursuant to titles II and V of the concurrent resolution on the budget for fiscal year 2018 (bill formerly known as the Tax Cuts and Jobs Act) Draft legislation relating to economic activity in Puerto Rico
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL BACHNER | — |
| COURTNEY PIRON | — |
| STEPHEN SCANGO | — |
Copyright/Patent/Trademark CPT
H.R. 4117: Competitive Deals Resulting in Unleashed Generics and Savings Act of 2017 or the Competitive DRUGS Act of 2017 - Patent Settlements H.R. 5340: The Support Technology & Research for Our Nations Growth and Economic Resilience (STRONGER) Patents Act of 2018 - Provisions related to reforms of Patent Trial and Appeal Board (PTAB) proceedings and other patent system reforms S. 124: Preserve Access to Affordable Generics Act - Provisions related to patent settlements S. 1390: STRONGER Patents Act of 2017 - Provisions related to reforms of PTAB proceedings and other patent system reforms Biopharmaceutical innovation and patent policy issues Patent litigation reform issues and issues related to post-grant proceeding at the PTO Draft legislation related to notification of agreements to the FTC and DOJ
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL BACHNER | — |
| COURTNEY PIRON | — |
| STEPHEN SCANGO | — |
Health Issues HCR
H.R. 4710: 340B Protecting Access for the Underserved and Safety-net Entities Act or PAUSE Act - Provisions related to the 340B program H.R. 5598: 340B Optimization Act - Provisions related to transparency in the 340B program H.R. 6071: SERV Communities Act - Provisions related to transparency in the 340B program S. 1131: Fair Accountability and Innovative Research Drug Pricing Act of 2017 - Provisions related to drug pricing S. 2312: HELP Act - Provisions related to 340B program S. 2453: Ensuring the Value of the 340B Program Act of 2018 - Provisions to increase transparency in the 340B program Drug cost and pricing policy issues Transparency policy issues Drug importation and counterfeiting policy issues 340B drug discount program policy issues
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL BACHNER | — |
| BINTA BEARD New | 9/2009-9/2010: Legislative Assistant/AAAS Fellow for Rep. Edward J. Markey; 9/2010-4/2014: Legislative Assistant, Senator Richard J. Durbin |
| HAYDEN RHUDY KENNEDY | Sen Orrin Hatch, 1/2011-9/2013 Senior Health Policy Advisor: Sen Mike Enzi, Senate HELP Cmt. 11/2007-1/2011 Research Asst, Prof Staff Member; Sen Issakson, 3/2005-11/2007; Staff Asst, Asst Sched; Health LC |
| COURTNEY PIRON | — |
| STEPHEN SCANGO | — |
Medicare/Medicaid MMM
S. 637: Creating Transparency to Have Drug Rebates Unlocked (C-THRU) Act of 2017 - Provisions related to transparency of prescription drug pricing and pharmacy benefit managers S. 1348: Stopping the Pharmaceutical Industry from Keeping Drugs Expensive (SPIKE) Act of 2017 - Provisions related to increases in the wholesale acquisition costs of prescription drugs Department of Health and Human Services (HHS) drug policy issues and regulatory policy issues Part D policy issues including non-interference and rebates policy issues Transparency policy issues Anti-Kickback Statute policy issues Center for Medicare and Medicaid Innovation (CMMI) policy issues Final Rule; Calendar Year (CY) 2018 Hospital Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Center (ASC) Payment System final rule with comment period (CMS-1678-FC) - Revisions to the Medicare hospital outpatient prospective payment system (OPPS) and the Medicare ambulatory surgical center (ASC) payment system for CY 2018 Proposed Rule: Medicare Program; Contract Year 2019 Policy and Technical Changes to the Medicare Advantage, Medicare Cost Plan, Medicare Fee-for-Service, the Medicare Prescription Drug Benefit Programs, and the PACE Program (CMS-4182-P)
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL BACHNER | — |
| HAYDEN RHUDY KENNEDY | Sen Orrin Hatch, 1/2011-9/2013 Senior Health Policy Advisor: Sen Mike Enzi, Senate HELP Cmt. 11/2007-1/2011 Research Asst, Prof Staff Member; Sen Issakson, 3/2005-11/2007; Staff Asst, Asst Sched; Health LC |
| COURTNEY PIRON | — |
| STEPHEN SCANGO | — |
Budget/Appropriations BUD
H.R.6157: Department of Defense and Labor, Health and Human Services, and Education Appropriations Act, 2019 and Continuing Appropriations Act, 2019
| Lobbyist | Covered position, as disclosed |
|---|---|
| DANIEL BACHNER | — |
| COURTNEY PIRON | — |
| STEPHEN SCANGO | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.